by Life Science Newswire | Apr 22, 2020 | Corporate, Finance & Investor, COVID-19
Former Cepheid CEO joins as company launches an accelerated program for the world’s first instrument-free molecular test for COVID-19 Sense Biodetection Limited (Sense) has today announced the appointment of John Bishop as non-executive director. John was the Chief...
by Life Science Newswire | Jan 9, 2020 | Biotechnology, Clinical diagnostics, Corporate, Finance & Investor, Drug discovery, Drug Discovery & Development, Healthcare, Pharma
Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumors for attack and destruction by the immune system Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for...
by Life Science Newswire | Dec 18, 2019 | Corporate, Finance & Investor, Drug Discovery & Development, Pharma
The financing will accelerate the development of first-in-class therapies in autoimmune disease and immuno-oncology Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer,...
by Life Science Newswire | Dec 12, 2019 | Corporate, Finance & Investor, Drug Discovery & Development, Pharma
TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, has today announced its corporate name change to SPT Labtech effective from January 6, 2020. The change of name is a contractual...
by Life Science Newswire | Dec 11, 2019 | Clinical Research & Trials, Corporate, Finance & Investor, Diagnostics & Hospital Laboratory, Pharma
Inceptua announced today that Stefan Fraenkel has been appointed CEO effective 1 January 2020. Alan Raffensperger is appointed Executive Vice-Chairman of the Inceptua Group. Inceptua – a pharmaceutical company and service partner spanning throughout the product...
by Life Science Newswire | Dec 5, 2019 | Biomanufacturing, Biotechnology, Clinical Research & Trials, Corporate, Finance & Investor, Diagnostics & Hospital Laboratory, Drug Discovery & Development, Pharma
Inceptua announced today that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January,...
